Navegar

Colección

Datos Estadísticas

Artículo

Croci, D.O.; Salatino, M.; Rubinstein, N.; Cerliani, J.P.; Cavallin, L.E.; Leung, H.J.; Ouyang, J.; Ilarregui, J.M.; Toscano, M.A.; Domaica, C.I.; Croci, M.C.; Shipp, M.A.; Mesri, E.A.; Albini, A.; Rabinovich, G.A. "Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" (2012) Journal of Experimental Medicine. 209(11):1985-2000
Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

Kaposi's sarcoma (KS), a multifocal vascular neoplasm linked to human herpesvirus-8 (HHV-8/KS-associated herpesvirus [KSHV]) infection, is the most common AIDS-associated malignancy. Clinical management of KS has proven to be challenging because of its prevalence in immunosuppressed patients and its unique vascular and inflammatory nature that is sustained by viral and host-derived paracrine-acting factors primarily released under hypoxic conditions. We show that interactions between the regulatory lectin galectin-1 (Gal-1) and specific target N-glycans link tumor hypoxia to neovascularization as part of the pathogenesis of KS. Expression of Gal-1 is found to be a hallmark of human KS but not other vascular pathologies and is directly induced by both KSHV and hypoxia. Interestingly, hypoxia induced Gal-1 through mechanisms that are independent of hypoxia-inducible factor (HIF) 1α and HIF-2α but involved reactive oxygen species-dependent activation of the transcription factor nuclear factor κB. Targeted disruption of Gal-1-N-glycan interactions eliminated hypoxia-driven angiogenesis and suppressed tumorigenesis in vivo. Therapeutic administration of a Gal-1-specific neutralizing mAb attenuated abnormal angiogenesis and promoted tumor regression in mice bearing established KS tumors. Given the active search for HIF-independent mechanisms that serve to couple tumor hypoxia to pathological angiogenesis, our findings provide novel opportunities not only for treating KS patients but also for understanding and managing a variety of solid tumors. © 2012 Croci et al.

Registro:

Documento: Artículo
Título:Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma
Autor:Croci, D.O.; Salatino, M.; Rubinstein, N.; Cerliani, J.P.; Cavallin, L.E.; Leung, H.J.; Ouyang, J.; Ilarregui, J.M.; Toscano, M.A.; Domaica, C.I.; Croci, M.C.; Shipp, M.A.; Mesri, E.A.; Albini, A.; Rabinovich, G.A.
Filiación:Laboratorio de Inmunopatología, Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigaciones Científicas y Técnicas, 1428 Buenos Aires, Argentina
División Inmunogenética, Hospital de Clínicas José de San Martín, Universidad de Buenos Aires, 1120 Buenos Aires, Argentina
Viral Oncology Program, Sylvester Comprehensive Cancer Center, Miami Center for AIDS Research, Department of Microbiology and Immunology, Miller School of Medicine, University of Miami, Miami, FL 33136, United States
Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA 02215, United States
Laboratorio de Patología, Facultad de Ciencias Médicas, Universidad Nacional del Comahue, 8324 Cipolletti, Argentina
Polo Scientifico e Tecnologico, Istituto di Ricovero e Cura a Carattere Scientifico MultiMedica, 20138 Milano, Italy
Departamento de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, 1428 Buenos Aires, Argentina
Palabras clave:galectin 1; glycan; hypoxia inducible factor 1alpha; hypoxia inducible factor 2alpha; immunoglobulin enhancer binding protein; messenger RNA; monoclonal antibody; reactive oxygen metabolite; angiogenesis; animal cell; animal experiment; animal model; animal tissue; apoptosis; article; carcinogenesis; cell growth; cell invasion; cell migration; cell proliferation; controlled study; human; human cell; human tissue; hypoxia; in vivo study; Kaposi sarcoma; male; mouse; nonhuman; priority journal; protein expression; protein function; protein protein interaction; protein targeting; spindle cell; tumor regression; Animals; Anoxia; Antibodies, Monoclonal; Antibodies, Neutralizing; Cell Hypoxia; Cell Line, Tumor; Cells, Cultured; Galectin 1; Gene Expression Regulation, Neoplastic; HEK293 Cells; Herpesvirus 8, Human; Host-Pathogen Interactions; Humans; Immunoblotting; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Nude; Neovascularization, Pathologic; Polysaccharides; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; Sarcoma, Kaposi; Xenograft Model Antitumor Assays
Año:2012
Volumen:209
Número:11
Página de inicio:1985
Página de fin:2000
DOI: http://dx.doi.org/10.1084/jem.20111665
Título revista:Journal of Experimental Medicine
Título revista abreviado:J. Exp. Med.
ISSN:00221007
CODEN:JEMEA
CAS:galectin 1, 258495-34-0; Antibodies, Monoclonal; Antibodies, Neutralizing; Galectin 1; Polysaccharides
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_00221007_v209_n11_p1985_Croci.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00221007_v209_n11_p1985_Croci

Referencias:

  • Albini, A., Morini, M., D'Agostini, F., Ferrari, N., Campelli, F., Arena, G., Noonan, D.M., De Flora, S., Inhibition of angiogenesis-driven Kaposi's sarcoma tumor growth in nude mice by oral N-acetylcysteine (2001) Cancer Res, 61, pp. 8171-8178
  • Alcendor, D.J., Knobel, S.M., Desai, P., Zhu, W.Q., Vigil, H.E., Hayward, G.S., KSHV downregulation of galectin-3 in Kaposi's sarcoma (2010) Glycobiology, 20, pp. 521-532. , http://dx.doi.org/10.1093/glycob/cwp204
  • Banh, A., Zhang, J., Cao, H., Bouley, D.M., Kwok, S., Kong, C., Giaccia, A.J., Le, Q.T., Tumor galectin-1 mediates tumor growth and metastasis through regulation of T-cell apoptosis (2011) Cancer Res, 71, pp. 4423-4431. , http://dx.doi.org/10.1158/0008-5472.CAN-10-4157
  • Casper, C., The increasing burden of HIV-associated malignancies in resource-limited regions (2011) Annu. Rev. Med, 62, pp. 157-170. , http://dx.doi.org/10.1146/annurev-med-050409-103711
  • Cedeno-Laurent, F., Watanabe, R., Teague, J.E., Kupper, T.S., Clark, R.A., Dimitroff, C.J., Galectin-1 inhibits the viability, proliferation, and Th1 cytokine production of nonmalignant T cells in patients with leukemic cutaneous T-cell lymphoma (2012) Blood, 119, pp. 3534-3538. , http://dx.doi.org/10.1182/blood-2011-12-396457
  • Cesarman, E., Mesri, E.A., Gershengorn, M.C., Viral G protein- coupled receptor and Kaposi's sarcoma: a model of paracrine neoplasia? (2000) J. Exp. Med, 191, pp. 417-422. , http://dx.doi.org/10.1084/jem.191.3.417
  • Chaisuparat, R., Hu, J., Jham, B.C., Knight, Z.A., Shokat, K.M., Montaner, S., Dual inhibition of PI3Kalpha and mTOR as an alternative treatment for Kaposi's sarcoma (2008) Cancer Res, 68, pp. 8361-8368. , http://dx.doi.org/10.1158/0008-5472.CAN-08-0878
  • Chan, D.A., Kawahara, T.L., Sutphin, P.D., Chang, H.Y., Chi, J.T., Giaccia, A.J., Tumor vasculature is regulated by PHD2-mediated angiogenesis and bone marrow-derived cell recruitment (2009) Cancer Cell, 15, pp. 527-538. , http://dx.doi.org/10.1016/j.ccr.2009.04.010
  • Chung, A.S., Ferrara, N., Developmental and pathological angiogenesis (2011) Annu. Rev. Cell Dev. Biol, 27, pp. 563-584. , http://dx.doi.org/10.1146/annurev-cellbio-092910-154002
  • Cornelissen, M., Van der Kuyl, A.C., Van den Burg, R., Zorgdrager, F., van Noesel, C.J.M., Goudsmit, J., Gene expression profile of AIDS-related Kaposi's sarcoma (2003) BMC Cancer, 3, p. 7. , http://dx.doi.org/10.1186/1471-2407-3-7
  • Delgado, V.M.C., Nugnes, L.G., Colombo, L.L., Troncoso, M.F., Fernández, M.M., Malchiodi, E.L., Frahm, I., Rabinovich, G.A., Modulation of endothelial cell migration and angiogenesis: a novel function for the "tandem-repeat" lectin galectin-8 (2011) FASEB J, 25, pp. 242-254. , http://dx.doi.org/10.1096/fj.09-144907
  • Favre, D., Lederer, S., Kanwar, B., Ma, Z.M., Proll, S., Kasakow, Z., Mold, J., Baskin, C.R., Critical loss of the balance between Th17 and T regulatory cell populations in pathogenic SIV infection (2009) PLoS Pathog, 5, pp. e1000295. , http://dx.doi.org/10.1371/journal.ppat.1000295
  • Fernández, G.C., Ilarregui, J.M., Rubel, C.J., Toscano, M.A., Gómez, S.A., Beigier Bompadre, M., Isturiz, M.A., Palermo, M.S., Galectin-3 and soluble fibrinogen act in concert to modulate neutrophil activation and survival: involvement of alternative MAPK pathways (2005) Glycobiology, 15, pp. 519-527. , http://dx.doi.org/10.1093/glycob/cwi026
  • Fitzpatrick, S.F., Tambuwala, M.M., Bruning, U., Schaible, B., Scholz, C.C., Byrne, A., O'Connor, A., Garvey, J.F., An intact canonical NF-kB pathway is required for inflammatory gene expression in response to hypoxia (2011) J. Immunol, 186, pp. 1091-1096. , http://dx.doi.org/10.4049/jimmunol.1002256
  • Fraisl, P., Mazzone, M., Schmidt, T., Carmeliet, P., Regulation of angiogenesis by oxygen and metabolism (2009) Dev. Cell, 16, pp. 167-179. , http://dx.doi.org/10.1016/j.devcel.2009.01.003
  • Ganem, D., KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine (2010) J. Clin. Invest, 120, pp. 939-949. , http://dx.doi.org/10.1172/JCI40567
  • Haque, M., Davis, D.A., Wang, V., Widmer, I., Yarchoan, R., Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) contains hypoxia response elements: relevance to lytic induction by hypoxia (2003) J. Virol, 77, pp. 6761-6768. , http://dx.doi.org/10.1128/JVI.77.12.6761-6768.2003
  • Hsieh, S.H., Ying, N.W., Wu, M.H., Chiang, W.F., Hsu, C.L., Wong, T.Y., Jin, Y.T., Chen, Y.L., Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753. , http://dx.doi.org/10.1038/sj.onc.1211029
  • Ilarregui, J.M., Croci, D.O., Bianco, G.A., Toscano, M.A., Salatino, M., Vermeulen, M.E., Geffner, J.R., Rabinovich, G.A., Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10 (2009) Nat. Immunol, 10, pp. 981-991. , http://dx.doi.org/10.1038/ni.1772
  • Ingrassia, L., Camby, I., Lefranc, F., Mathieu, V., Nshimyumukiza, P., Darro, F., Kiss, R., Anti-galectin compounds as potential anticancer drugs (2006) Curr. Med. Chem, 13, pp. 3513-3527. , http://dx.doi.org/10.2174/092986706779026219
  • Ito, K., Ralph, S.J., Inhibiting galectin-1 reduces murine lung metastasis with increased CD4(+) and CD8 (+) T cells and reduced cancer cell adherence (2012) Clin. Exp. Metastasis, 29, pp. 561-572. , http://dx.doi.org/10.1007/s10585-012-9471-7
  • Juszczynski, P., Ouyang, J., Monti, S., Rodig, S.J., Takeyama, K., Abramson, J., Chen, W., Shipp, M.A., The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma (2007) Proc. Natl. Acad. Sci. USA, 104, pp. 13134-13139. , http://dx.doi.org/10.1073/pnas.0706017104
  • Keith, B., Johnson, R.S., Simon, M.C., HIF1a and HIF2α: sibling rivalry in hypoxic tumour growth and progression (2012) Nat. Rev. Cancer., 12, pp. 9-22
  • Kuo, P.L., Hung, J.Y., Huang, S.K., Chou, S.H., Cheng, D.E., Jong, Y.J., Hung, C.H., Huang, M.S., Lung cancer-derived galectin-1 mediates dendritic cell anergy through inhibitor of DNA binding 3/IL-10 signaling pathway (2011) J. Immunol, 186, pp. 1521-1530. , http://dx.doi.org/10.4049/jimmunol.1002940
  • Le, Q.T., Shi, G., Cao, H., Nelson, D.W., Wang, Y., Chen, E.Y., Zhao, S., O'Byrne, K.J., Galectin-1: a link between tumor hypoxia and tumor immune privilege (2005) J. Clin. Oncol, 23, pp. 8932-8941. , http://dx.doi.org/10.1200/JCO.2005.02.0206
  • Liu, F.T., Rabinovich, G.A., Galectins as modulators of tumour progression (2005) Nat. Rev. Cancer, 5, pp. 29-41. , http://dx.doi.org/10.1038/nrc1527
  • Ma, Q., Cavallin, L.E., Yan, B., Zhu, S., Duran, E.M., Wang, H., Hale, L.P., Goldschmidt-Clermont, P.J., Antitumorigenesis of antioxidants in a transgenic Rac1 model of Kaposi's sarcoma (2009) Proc. Natl. Acad. Sci. USA, 106, pp. 8683-8688. , http://dx.doi.org/10.1073/pnas.0812688106
  • Ma, T., Jham, B.C., Hu, J., Friedman, E.R., Basile, J.R., Molinolo, A., Sodhi, A., Montaner, S., Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma (2010) Proc. Natl. Acad. Sci. USA, 107, pp. 14363-14368. , http://dx.doi.org/10.1073/pnas.1001065107
  • Markowska, A.I., Liu, F.T., Panjwani, N., Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response (2010) J. Exp. Med, 207, pp. 1981-1993. , http://dx.doi.org/10.1084/jem.20090121
  • Markowska, A.I., Jefferies, K.C., Panjwani, N., Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells (2011) J. Biol. Chem, 286, pp. 29913-29921. , http://dx.doi.org/10.1074/jbc.M111.226423
  • Martin, D., Galisteo, R., Ji, Y., Montaner, S., Gutkind, J.S., An NFkappaB gene expression signature contributes to Kaposi's sarcoma virus vGPCR-induced direct and paracrine neoplasia (2008) Oncogene, 27, pp. 1844-1852. , http://dx.doi.org/10.1038/sj.onc.1210817
  • Martin, D., Galisteo, R., Molinolo, A.A., Wetzker, R., Hirsch, E., Gutkind, J.S., PI3Kg mediates kaposi's sarcoma-associated herpesvirus vGPCR-induced sarcomagenesis (2011) Cancer Cell, 19, pp. 805-813. , http://dx.doi.org/10.1016/j.ccr.2011.05.005
  • Mesri, E.A., Cesarman, E., Boshoff, C., Kaposi's sarcoma and its associated herpesvirus (2010) Nat. Rev. Cancer, 10, pp. 707-719. , http://dx.doi.org/10.1038/nrc2888
  • Mizukami, Y., Jo, W.S., Duerr, E.M., Gala, M., Li, J., Zhang, X., Zimmer, M.A., Kohgo, Y., Induction of interleukin-8 preserves the angiogenic response in HIF-1a-deficient colon cancer cells (2005) Nat. Med., 11, pp. 992-997
  • Montaner, S., Sodhi, A., Servitja, J.M., Ramsdell, A.K., Barac, A., Sawai, E.T., Gutkind, J.S., The small GTPase Rac1 links the Kaposi sarcoma-associated herpesvirus vGPCR to cytokine secretion and paracrine neoplasia (2004) Blood, 104, pp. 2903-2911. , http://dx.doi.org/10.1182/blood-2003-12-4436
  • Montaner, S., Sodhi, A., Ramsdell, A.K., Martin, D., Hu, J., Sawai, E.T., Gutkind, J.S., The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma (2006) Cancer Res, 66, pp. 168-174. , http://dx.doi.org/10.1158/0008-5472.CAN-05-1026
  • Mutlu, A.D., Cavallin, L.E., Vincent, L., Chiozzini, C., Eroles, P., Duran, E.M., Asgari, Z., Hilsher, C., In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma (2007) Cancer Cell, 11, pp. 245-258. , http://dx.doi.org/10.1016/j.ccr.2007.01.015
  • Myoung, J., Ganem, D., Generation of a doxycycline-inducible KSHV producer cell line of endothelial origin: maintenance of tight latency with efficient reactivation upon induction (2011) J. Virol. Methods, 174, pp. 12-21. , http://dx.doi.org/10.1016/j.jviromet.2011.03.012
  • Nangia-Makker, P., Honjo, Y., Sarvis, R., Akahani, S., Hogan, V., Pienta, K.J., Raz, A., Galectin-3 induces endothelial cell morphogenesis and angiogenesis (2000) Am. J. Pathol, 156, pp. 899-909. , http://dx.doi.org/10.1016/S0002-9440(10)64959-0
  • Norling, L.V., Sampaio, A.L., Cooper, D., Perretti, M., Inhibitory control of endothelial galectin-1 on in vitro and in vivo lymphocyte trafficking (2008) FASEB J, 22, pp. 682-690. , http://dx.doi.org/10.1096/fj.07-9268com
  • Ouyang, J., Juszczynski, P., Rodig, S.J., Green, M.R., O'Donnell, E., Currie, T., Armant, M., Rabinovich, G.A., Viral induction and targeted inhibition of galectin-1 in EBV+ posttransplant lymphoproliferative disorders (2011) Blood, 117, pp. 4315-4322. , http://dx.doi.org/10.1182/blood-2010-11-320481
  • Paulson, J.C., Blixt, O., Collins, B.E., Sweet spots in functional glycomics (2006) Nat. Chem. Biol, 2, pp. 238-248. , http://dx.doi.org/10.1038/nchembio785
  • Paz, A., Haklai, R., Elad-Sfadia, G., Ballan, E., Kloog, Y., Galectin-1 binds oncogenic H-Ras to mediate Ras membrane anchorage and cell transformation (2001) Oncogene, 20, pp. 7486-7493. , http://dx.doi.org/10.1038/sj.onc.1204950
  • Rabinovich, G.A., Croci, D.O., Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer (2012) Immunity, 36, pp. 322-335. , http://dx.doi.org/10.1016/j.immuni.2012.03.004
  • Rabinovich, G.A., Daly, G., Dreja, H., Tailor, H., Riera, C.M., Hirabayashi, J., Chernajovsky, Y., Recombinant galectin-1 and its genetic delivery suppress collagen-induced arthritis via T cell apoptosis (1999) J. Exp. Med, 190, pp. 385-398. , http://dx.doi.org/10.1084/jem.190.3.385
  • Rabinovich, G.A., Cumashi, A., Bianco, G.A., Ciavardelli, D., Iurisci, I., D'Egidio, M., Piccolo, E., Iacobelli, S., Synthetic lactulose amines: novel class of anticancer agents that induce tumor-cell apoptosis and inhibit galectin-mediated homotypic cell aggregation and endothelial cell morphogenesis (2006) Glycobiology, 16, pp. 210-220. , http://dx.doi.org/10.1093/glycob/cwj056
  • Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A.S., Nizet, V., Johnson, R.S., Karin, M., NF- kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α (2008) Nature, 453, pp. 807-811. , http://dx.doi.org/10.1038/nature06905
  • Rubinstein, N., Alvarez, M., Zwirner, N.W., Toscano, M.A., Ilarregui, J.M., Bravo, A., Mordoh, J., Rabinovich, G.A., Targeted inhibition of galectin-1 gene expression in tumor cells results in heightened T cell-mediated rejection; A potential mechanism of tumor-immune privilege (2004) Cancer Cell, 5, pp. 241-251. , http://dx.doi.org/10.1016/S1535-6108(04)00024-8
  • Salomonsson, E., Thijssen, V.L., Griffioen, A.W., Nilsson, U.J., Leffler, H., The anti-angiogenic peptide anginex greatly enhances galectin-1 binding affinity for glycoproteins (2011) J. Biol. Chem, 286, pp. 13801-13804. , http://dx.doi.org/10.1074/jbc.C111.229096
  • St-Pierre, C., Manya, H., Ouellet, M., Clark, G.F., Endo, T., Tremblay, M.J., Sato, S., Host-soluble galectin-1 promotes HIV-1 replication through a direct interaction with glycans of viral gp120 and host CD4 (2011) J. Virol, 85, pp. 11742-11751. , http://dx.doi.org/10.1128/JVI.05351-11
  • Sun, Q., Matta, H., Lu, G., Chaudhary, P.M., Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation (2006) Oncogene, 25, pp. 2717-2726. , http://dx.doi.org/10.1038/sj.onc.1209298
  • Tang, D., Yuan, Z., Xue, X., Lu, Z., Zhang, Y., Wang, H., Chen, M., Zhu, Y., High expression of Galectin-1 in pancreatic stellate cells plays a role in the development and maintenance of an immunosuppressive microenvironment in pancreatic cancer (2012) Int. J. Cancer, 130, pp. 2337-2348. , http://dx.doi.org/10.1002/ijc.26290
  • Thijssen, V.L., Postel, R., Brandwijk, R.J., Dings, R.P., Nesmelova, I., Satijn, S., Verhofstad, N., Bakkers, J., Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy (2006) Proc. Natl. Acad. Sci. USA, 103, pp. 15975-15980. , http://dx.doi.org/10.1073/pnas.0603883103
  • Thijssen, V.L., Barkan, B., Shoji, H., Aries, I.M., Mathieu, V., Deltour, L., Hackeng, T.M., Griffioen, A.W., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res, 70, pp. 6216-6224. , http://dx.doi.org/10.1158/0008-5472.CAN-09-4150
  • Toscano, M.A., Bianco, G.A., Ilarregui, J.M., Croci, D.O., Correale, J., Hernandez, J.D., Zwirner, N.W., Rabinovich, G.A., Differential glycosylation of TH1 TH2 and TH-17 effector cells selectively regulates susceptibility to cell death (2007) Nat. Immunol, 8, pp. 825-834. , http://dx.doi.org/10.1038/ni1482
  • Toscano, M.A., Campagna, L., Molinero, L.L., Cerliani, J.P., Croci, D.O., Ilarregui, J.M., Fuertes, M.B., Zwirner, N.W., Nuclear factor (NF)-kB controls expression of the immunoregulatory glycan-binding protein galectin-1 (2011) Mol. Immunol, 48, pp. 1940-1949. , http://dx.doi.org/10.1016/j.molimm.2011.05.021
  • Tsuboi, S., Sutoh, M., Hatakeyama, S., Hiraoka, N., Habuchi, T., Horikawa, Y., Hashimoto, Y., Koie, T., A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycans (2011) EMBO J, 30, pp. 3173-3185. , http://dx.doi.org/10.1038/emboj.2011.215
  • Vieira, J., O'Hearn, P.M., Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression (2004) Virology, 325, pp. 225-240. , http://dx.doi.org/10.1016/j.virol.2004.03.049
  • Wang, H.W., Trotter, M.W., Lagos, D., Bourboulia, D., Henderson, S., Mäkinen, T., Elliman, S., Boshoff, C., Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma (2004) Nat. Genet, 36, pp. 687-693. , http://dx.doi.org/10.1038/ng1384
  • Wu, F.Y., Tang, Q.Q., Chen, H., ApRhys, C., Farrell, C., Chen, J., Fujimuro, M., Hayward, G.S., Lytic replication-associated protein (RAP) encoded by Kaposi sarcoma-associated herpesvirus causes p21CIP-1-mediated G1 cell cycle arrest through CCAAT/enhancer-binding protein-a (2002) Proc. Natl. Acad. Sci. USA, 99, pp. 10683-10688. , http://dx.doi.org/10.1073/pnas.162352299
  • Ye, F., Zhou, F., Bedolla, R.G., Jones, T., Lei, X., Kang, T., Guadalupe, M., Gao, S.J., Reactive oxygen species hydrogen peroxide mediates Kaposi's sarcoma-associated herpesvirus reactivation from latency (2011) PLoS Pathog, 7, pp. e1002054. , http://dx.doi.org/10.1371/journal.ppat.1002054
  • Zhao, X.Y., Chen, T.T., Xia, L., Guo, M., Xu, Y., Yue, F., Jiang, Y., Zhao, K.W., Hypoxia inducible factor-1 mediates expression of galectin-1: the potential role in migration/invasion of colorectal cancer cells (2010) Carcinogenesis, 31, pp. 1367-1375. , http://dx.doi.org/10.1093/carcin/bgq116
  • Zhao, X.Y., Zhao, K.W., Jiang, Y., Zhao, M., Chen, G.Q., Synergistic induction of galectin-1 by CCAAT/enhancer binding protein a and hypoxia-inducible factor 1a and its role in differentiation of acute myeloid leukemic cells (2011) J. Biol. Chem, 286, pp. 36808-36819. , http://dx.doi.org/10.1074/jbc.M111.247262

Citas:

---------- APA ----------
Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., Ouyang, J.,..., Rabinovich, G.A. (2012) . Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. Journal of Experimental Medicine, 209(11), 1985-2000.
http://dx.doi.org/10.1084/jem.20111665
---------- CHICAGO ----------
Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., et al. "Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" . Journal of Experimental Medicine 209, no. 11 (2012) : 1985-2000.
http://dx.doi.org/10.1084/jem.20111665
---------- MLA ----------
Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., et al. "Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma" . Journal of Experimental Medicine, vol. 209, no. 11, 2012, pp. 1985-2000.
http://dx.doi.org/10.1084/jem.20111665
---------- VANCOUVER ----------
Croci, D.O., Salatino, M., Rubinstein, N., Cerliani, J.P., Cavallin, L.E., Leung, H.J., et al. Disrupting galectin-1 interactions with N-glycans suppresses hypoxia-driven angiogenesis and tumorigenesis in Kaposi's sarcoma. J. Exp. Med. 2012;209(11):1985-2000.
http://dx.doi.org/10.1084/jem.20111665